I.CA Profile & Description — IntelliPharmaCeutics International Inc
Intellipharmaceutics International is engaged in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Co.'s patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, Co. has developed several drug delivery systems, a pipeline of products and product candidates in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.